Pre-Market 02 Feb 2026: ISRG Intuitive Surgical NASDAQ $504.22: AI stocks note

ISRG stock opens the pre-market at $504.22 on 02 Feb 2026 after a small pullback of -0.66%. Investors are watching Intuitive Surgical, Inc. (NASDAQ: ISRG) for AI-driven robotics trends and recurring service revenue. Key metrics show EPS 7.87 and a PE of 64.07, while volume sits near 1,697,253.00 shares. This update links recent price action to fundamentals, technicals, and our AI-driven outlook from Meyka AI.

ISRG stock: price, volume and near-term technicals

ISRG stock trades at $504.22 with pre-market range visible from the prior session low $501.39 to high $511.03. Daily volume is 1,697,253.00 vs. average 2,134,666.00, a relative volume of 0.64. Momentum readings show RSI 65.69 and MACD histogram 0.11, suggesting constructive short-term bias but limited upside without fresh catalysts. Price sits below the 50-day average $558.90 and slightly below the 200-day average $516.26, which frames near-term resistance and support.

ISRG stock: fundamentals and valuation snapshot

Intuitive Surgical, Inc. (NASDAQ: ISRG) posts EPS 7.87 and a trailing PE of 64.07, reflecting premium valuation for a market-cap of $180,751,018,813.00. Revenue per share is 28.36 and free cash flow per share is 6.40, with current ratio 4.73. Price-to-sales sits near 17.99 and price-to-book near 10.59, indicating expensive multiples versus the Medical – Instruments & Supplies group. Robust margins (net margin 28.38%) support the premium, but valuation compresses upside without growth acceleration.

ISRG stock: growth, risks and sector context

Intuitive Surgical reported FY growth with revenue up 17.24% and free cash flow growth of 73.93% year-over-year. The company benefits from recurring service revenue and product upgrades tied to robotic surgery adoption. Key risks include high valuation, procedure volume sensitivity, and supply chain pressures. In the Health care sector, capital equipment leaders trade on adoption narratives tied to AI and data services, which helps explain ISRG’s price action.

Meyka AI grade and ISRG stock technical analysis

Meyka AI rates ISRG with a score out of 100: 74.57 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. Technicals show ATR 11.47 and Bollinger mid at $566.22, suggesting a trading band up to $590.15. Short-term traders should watch RSI and the 50-day trend for confirmation before adding exposure.

ISRG stock: analyst sentiment, price targets and model forecast

Broker consensus lists 16 Buys, 4 Holds, and 2 Sells. While an aggregate price target is not available in the feed, our model gives multi-horizon projections. Meyka AI’s forecast model projects a yearly price of $605.93, implying notable upside from the current $504.22 level. Forecasts are model-based projections and not guarantees. For real-time headlines, see recent coverage on CNBC and extended quotes on MarketWatch.

Trading strategy for AI stocks exposure via ISRG stock

Position sizing should reflect valuation risk and sector exposure. Consider staggered buys near technical support around $500.00 and trim on strength near the 50-day average $558.90 or our yearly forecast. Use protective stops below recent swing low $501.39 for short-term trades. For long-term AI robotics exposure, pair ISRG stock with broader healthcare and AI-capable medical device names to diversify execution and product-cycle risk. See company detail on our Meyka stock page for ISRG for real-time signals: Meyka ISRG page.

Final Thoughts

ISRG stock opens pre-market at $504.22 on 02 Feb 2026 with mixed technicals and premium valuation. The company shows strong profitability, with net margin 28.38% and free cash flow per share 6.40, but trades at rich multiples: PE 64.07 and P/S 17.99. Meyka AI’s forecast model projects a yearly target of $605.93, an implied upside of 20.17% versus the current price of $504.22. Meyka AI rates ISRG 74.57/100 (B+, BUY), a grade that balances growth, sector positioning, and valuation. Forecasts are model-based projections and not guarantees. Investors should weigh the AI-driven robotics upside against elevated multiples and near-term procedure cycle risk, and size positions accordingly.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.